J&J plans late-stage trial for lupus candidate after Phase 2 successnews2026-01-06T19:11:01+00:00January 6th, 2026|Endpoints News|
Balancing Clinical Autonomy and Business Interests in Corporate Practice of Medicinenews2026-01-06T17:07:46+00:00January 6th, 2026|Medical Device News Magazine|
Boosting Oral Health with Quality Dental Care in St Georgenews2026-01-06T16:56:14+00:00January 6th, 2026|Medical Device News Magazine|
Powered by Roncadelle Operations’ SafeR® Passive Safety Technologynews2026-01-06T16:48:59+00:00January 6th, 2026|Medical Device News Magazine|
Bright Minds’ shares soar on positive Phase 2 seizure reduction datanews2026-01-06T16:33:16+00:00January 6th, 2026|Endpoints News|
Alumis’ TYK2 drug succeeds in key psoriasis studies, will seek FDA approvalnews2026-01-06T16:22:38+00:00January 6th, 2026|Endpoints News|
Amgen to acquire Dark Blue Therapeutics for up to $840Mnews2026-01-06T15:49:45+00:00January 6th, 2026|Endpoints News|
1st of Its Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Managementnews2026-01-06T15:25:58+00:00January 6th, 2026|Medical Device News Magazine|
